KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Depreciation & Amortization (IS) (2023 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Depreciation & Amortization (IS) for 3 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) fell 7.1% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 12.57% year-over-year, with the annual reading at $16.0 million for FY2025, 8.26% down from the prior year.
  • Depreciation & Amortization (IS) hit $3.7 million in Q4 2025 for Adaptive Biotechnologies, down from $4.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $5.8 million in Q3 2023 to a low of $2.8 million in Q4 2023.
  • Historically, Depreciation & Amortization (IS) has averaged $4.5 million across 3 years, with a median of $4.2 million in 2024.
  • Biggest YoY gain for Depreciation & Amortization (IS) was 42.43% in 2024; the steepest drop was 27.88% in 2024.
  • Year by year, Depreciation & Amortization (IS) stood at $2.8 million in 2023, then skyrocketed by 42.43% to $3.9 million in 2024, then dropped by 7.1% to $3.7 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for ADPT at $3.7 million in Q4 2025, $4.0 million in Q3 2025, and $4.1 million in Q2 2025.